bad headache; body aches/If I moved my body hurt; dizzy; nauseated; fatigue; frequent urination; chills; 24 hours in bed; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01Oct2021 16:30 (Lot number: 301358A) at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Type 2 diabetic" (unspecified if ongoing). Concomitant medication(s) included: FLUZONE QUADRIVALENT, administration date 09Sep2021; SHINGRIX, administration date 09Sep2021. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6202, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 26Feb2021, when the patient was 62 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL1283, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 05Feb2021, when the patient was 62 years old, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "bad headache"; PAIN (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "body aches/If I moved my body hurt"; DIZZINESS (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "dizzy"; NAUSEA (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "nauseated"; FATIGUE (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "fatigue"; POLLAKIURIA (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "frequent urination"; CHILLS (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "chills"; BEDRIDDEN (non-serious) with onset 02Oct2021 09:00, outcome "recovered" (2021), described as "24 hours in bed". Therapeutic measures were taken as a result of headache, pain, dizziness, nausea, fatigue, pollakiuria, chills, bedridden.  No follow-up attempts are possible. No further information is expected.  Additional Information: It was reported that, Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient received other medications within 2 weeks of vaccination. The patient received other vaccine within 4weeks, other vaccine Fluzone Quad Sanofi PS, vaccine date: 09Sep2021, dose number: 1, vaccine location: right arm. Other vaccine SHINGRIX Glaxosmith, Other vaccine vaccine date: 09Sep2021, Other vaccine dose number: 1, vaccine location: left arm. Adverse event: bad headache, body aches, dizzy, nauseated, fatigue, frequent urination, chills, 24 hours in bed. If I moved my body hurt and I got dizzy. Adverse event start date, time: 02Oct2021,09:00 AM. The patient was recovered from adverse events. The patient was taken self medicated with Tylenol as treatment for adverse events. Patient was not diagnosed with COVID-19 prior vaccination. Patient has not been tested for COVID-19 since vaccination. The patient had no known allergies.  Follow-Up (12Oct2021): Follow-up attempts are completed. No further information is expected.